Skip Navigation



International Immunology Advance Access published online on April 24, 2006

International Immunology, doi:10.1093/intimm/dxl023
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
18/6/871    most recent
dxl023v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Oroszlán, M.
Right arrow Articles by Cervenak, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oroszlán, M.
Right arrow Articles by Cervenak, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Japanese Society for Immunology. 2006. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org
Received August 9, 2005
Accepted March 10, 2006

Article

Proinflammatory changes in human umbilical cord vein endothelial cells can be induced neither by native nor by modified CRP

Melinda Oroszlán 1, Eszter Herczenik 2, Szabolcs Rugonfalvi-Kiss 3, Anja Roos 4 *, Alma J. Nauta 5, Mohamed R. Daha 5, Imre Gombos 6, István Karádi 7, László Romics 7, Zoltán Prohászka 7, George Füst 7, and László Cervenak 2

1 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary; Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands
2 Research Group of Metabolism and Atherosclerosis, Hungarian Academy of Sciences-Semmelweis University, Budapest, Hungary
3 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary
4 Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands; Present address: Department of Clinical Chemistry, L2-27, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands
5 Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands
6 Department of Immunology, Lóránd Eötvös University, Budapest, Hungary
7 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary; Research Group of Metabolism and Atherosclerosis, Hungarian Academy of Sciences-Semmelweis University, Budapest, Hungary

* To whom correspondence should be addressed.
Anja Roos, E-mail: a.roos{at}lumc.nl


   Abstract

The role of C-reactive protein (CRP) in atherosclerosis is controversial. It is not clear, either, if the presumed endothelium-activating effect of CRP resides in native CRP (nCRP) or in a conformational isoform of CRP known as modified CRP (mCRP). In the present study we evaluated and compared the effect of nCRP, recombinant modified CRP (rmCRP) and urea-modified CRP (umCRP) on human umbilical vein endothelial cells (HUVECs). CRP preparations were carefully analyzed by biochemical, immunological and cell biological methods in order to avoid endotoxin or sodium azide contamination as well as inappropriate conformational changes, which together had possibly been the main reason for the previously published controversial results. Neither nCRP nor mCRP showed significant cytotoxicity up to 100 µg ml-1 at 24 h but high concentrations of CRPs induced cell death at 48 h. rmCRP but not nCRP nor umCRP showed membrane binding to HUVEC by confocal microscopy. However, none of the CRP forms induced intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin expression or IL-8 production. Monocyte chemotactic protein-1 production was weakly inhibited by high concentration of both nCRP and rmCRP, analyzed by sandwich ELISA. Neither nCRP nor mCRP could induce pro-inflammatory changes in the phenotype of HUVECs. Therefore, our present findings do not support the notion that different isoforms of CRP alone have significant effects on inflammation of the vessel wall via an interaction with endothelial cells (ECs), although one cannot exclude the possibility that there may be significant differences among various types of ECs in the response to CRP.

Keywords: atherosclerosis; C-reactive protein; endothelium; inflammation.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
S. M. Nelson, N. Sattar, D. J. Freeman, J. D. Walker, and R. S. Lindsay
Inflammation and Endothelial Activation Is Evident at Birth in Offspring of Mothers With Type 1 Diabetes
Diabetes, November 1, 2007; 56(11): 2697 - 2704.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Rocker, D. E. Manolov, E. V. Kuzmenkina, K. Tron, H. Slatosch, J. Torzewski, and G. U. Nienhaus
Affinity of C-Reactive Protein toward Fc{gamma}RI Is Strongly Enhanced by the {gamma}-Chain
Am. J. Pathol., February 1, 2007; 170(2): 755 - 763.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.